How Apple Inc. (AAPL) Can Get ‘Close to a Trillion Dollars in Value’: Portfolio Manager

The portfolio manager broke down his bullish Apple Inc. (NASDAQ:AAPL) thesis into multiple phases, which include:

“One: it’s the world’s best retailer. If you had the ability to get at their retail profitability, it would be better than anyone else on the planet. The second thing is: it gets recurring revenue from the iPhone and the Apps on the iPad. The third thing is: it makes these devices […] it’s not really a consumer durable, it’s a consumer semi-durable.”

Additionally, Haverty mentions the “financial characteristics,” which include stellar margins, high ROI, and “not a lot of capital intensity,” at “half the multiple of Coca-Cola.”

Perhaps most importantly, Haverty discusses the prospects of Apple Inc. (NASDAQ:AAPL)’s decision not to place more of its cash flow into shareholders’ pockets, which he describes as “irresponsible” management. Here are his thoughts:

“The reality is right now, Apple could […] finance in the bond market at 1% and pay the interest and bring the cash over and give it to the shareholders. They could also finance at 1% and buy the stock and get a 16% return […] They’d flunk a finance class in any business school.”

To conclude, Haverty says that “it’s time the directors, I think, changed the playbook in terms of the cash management,” adding that “if they ever did that, I think the stock could be very close to a trillion dollars in value very, very quickly.”

Let us know your thoughts in the comments section below, and for more Apple Inc. (NASDAQ:AAPL) coverage, continue reading here:

The Apple iPad Could Be a Standalone Tech Monster

AT&T Leans on iPhone to Set Holiday Sales Record

One Very Bearish Prediction for Apple

Disclosure: I have no positions in any of the stocks mentioned above

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!